In a strategic alliance, Mark Cuban Cost Plus Drug Company said it would be teaming with pricing technology company Expion Health in an effort to address the rising costs of specialty drugs.
The idea is that the pricing capabilities of Cost Plus drugs will be integrated into Expion’s product suite. Expion Health CEO Karin Humphrey said this will allow the company to expand its search capabilities and increase the transparency of pharmacy cost management.
